“…Two other prodrugs, 4-S-cysteaminylphenol (4-S-CAP) and N-acetyl-4-S-cysteaminylphenol (N-Ac-4-S-CAP), were shown to inhibit thymidylate synthase and DNA synthesis in various melanoma cells, although the compounds were essentially nontoxic to nonmelanoma cells (Miura et al, 1990;Pankovich et al, 1990;Prezioso et al, 1992a,b) (Table 8). Partial inhibition of the cytotoxicity of these prodrugs was caused by the tyrosinase inhibitor phenylthiourea, indicating an important role for tyrosinase (Prezioso et al, 1992a). 4-S-CAP is metabolized by tyrosinase to 4-S-cysteaminylcatechol, which auto-oxidates to the ultimate toxin dihydro-1,4-benzothiazine-6,7-dione ( Fig.…”